Multicenter, open-label, trial of sarizotan in Parkinson disease patients with levodopa-induced dyskinesias (the SPLENDID Study). (Q44977032)
Jump to navigation
Jump to search
scientific article published in March 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Multicenter, open-label, trial of sarizotan in Parkinson disease patients with levodopa-induced dyskinesias (the SPLENDID Study). |
scientific article published in March 2004 |
Statements
1 reference
Multicenter, open-label, trial of sarizotan in Parkinson disease patients with levodopa-induced dyskinesias (the SPLENDID Study). (English)
1 reference
Olivier Rascol
1 reference
Christopher G Goetz
1 reference
C Warren Olanow
1 reference
John Nutt
1 reference
Philippe Damier
1 reference
Thomas Mueller
1 reference
Alexandru Serbanescu
1 reference
Frieda Deckers
1 reference
Hermann Russ
1 reference
1 March 2004
1 reference
1 reference
27
1 reference
2
1 reference
58-62
1 reference
Identifiers
1 reference
1 reference